Skip to the page

Data / Form D filings / Protibea Therapeutics, Inc.

Protibea Therapeutics, Inc.: Form D filings

Protibea Therapeutics, Inc., a health care company in Georgetown, TX, filed 2 Form D notices with the SEC between 2021 and 2025. The latest, on August 18, 2025, reports $200,000 sold of a $11.7 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1108 LEGACY CROSSING, Georgetown, TX, 78628
Phone
(915) 490-0715
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1864104

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 18, 2025New notice$11,700,000$200,000$11,500,0002Jul 30, 2025sec.gov
May 28, 2021New notice$1,200,000$770,000$430,0008May 10, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jim MoriartyExecutive Officer, Director
Yu GeDirector
William ChamberlinExecutive Officer, Director
Harry OkenDirector

Other health care companies in Texas that filed recently

Every Form D from the week of Aug 18, 2025 · All recent filings in Texas · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Protibea Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.